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Purpose: To describe an Australian pedigree of European descent with a variable autosomal dominant phenotype of:
pediatric cortical cataract (CC), asymmetric myopia with astigmatism, familial exudative vitreoretinopathy (FEVR), and
primary open-angle glaucoma (POAG).
Methods: Probands with CC, FEVR, and POAG were enrolled in three independent genetic eye studies in Tasmania.
Genealogy confirmed these individuals were closely related and subsequent examination revealed 11 other family
members with some or all of the associated disorders.
Results: Twelve individuals had CC thought to be of childhood onset, with one child demonstrating progressive lenticular
opacification.  One  individual  had  severe  retinal  detachment  while  five  others  had  dragged  retinal  vessels.  Seven
individuals had POAG. Seven individuals had myopia in at least one eye ≤-3 Diopters. DNA testing excluded mutations
in myocilin, trabecular meshwork inducible glucocorticoid response (MYOC) and tetraspanin 12 (TSPAN12). Haplotype
analysis excluded frizzled family receptor 4 (FZD4) and low density lipoprotein receptor-related protein 5 (LRP5), but
only partly excluded EVR3. Multipoint linkage analysis revealed multiple chromosomal single-nucleotide polymorphisms
(SNPs) of interest, but no statistically significant focal localization.
Conclusions: This unusual clustering of ophthalmic diseases suggests a possible single genetic cause for an apparently
new cataract syndrome. This family’s clinical ocular features may reflect the interplay between retinal disease with
lenticular changes and axial length in the development of myopia and glaucoma.
In  this  study,  we  describe  the  novel  overlapping
phenotype  of  congenital  cataract  (CC),  familial  exudative
vitreoretinopathy (FEVR), myopia, and primary open-angle
glaucoma (POAG) segregating in an apparently autosomal-
dominant fashion.
In Australia, myopia affects approximately 15% of the
population  [1],  POAG  affects  approximately  3%  of  the
population [2], CC occurs in approximately 2.2 out of every
10,000 births [3], and FEVR affects an estimated 7 out of
every 1000,000 people (derived from comparing 13 indexed
FEVR cases [4] to 420 CC cases [3]). If we were to consider
these diseases as completely independent clinical entities, the
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highly unlikely probability of a patient having all four diseases
simultaneously, or of the four diseases co-segregating, would
be approximately 1 in 148 billion. This denominator is more
than 20 times the total population of earth today.
Interestingly, to some extent these clinical entities can be
associated with each other. Many investigators have reported
the association of high myopia with cataract, glaucoma, and
retinal detachment [5]. Other associations are less common:
•anterior polar cataracts, seen in aniridia, are often
associated with glaucoma [6];
•rubella  embryopathy  is  associated  with  both
congenital glaucoma and CC [6];
•aphakic glaucoma is observed very frequently, and
cataract can develop as a complication of POAG-filtering
surgery [6];
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2118•retinal detachment is a feature of Stickler syndrome
and is associated often with cortical lens opacities [7];
•retinal detachment from retinopathy of prematurity
(ROP) is associated with myopia and cataract [8].
•Retinal dystrophies are associated with myopia and
posterior subcapsular cataracts [9].
Although researchers have identified genes associated
with each of these disorders, the genetic mechanisms and their
interactions still are not fully understood.
METHODS
We identified three closely-related index cases from three
genetic-eye-disease  studies:  VI:7  from  the  Glaucoma
Inheritance Study in Tasmania (GIST) [10], VIII:7 from the
Cataract  Inheritance  Study  in  South  Eastern  Australia
(CISSEA)  [3],  and  VIII:8  from  the  Familial  Retinal
Detachment Study (FRDA) [4]. The GIST study had ethical
approval from the Royal Hobart Hospital; the CISSEA and
FRDA studies had ethical approval from the Royal Victorian
Eye and Ear Hospital. In each case, the work was conducted
in accordance with the tenets of the Declaration of Helsinki.
When  we  realized  that  the  index  cases  were  a
grandmother and two of her grandchildren who were genetic
first cousins, we decided to examine the entire pedigree in
detail  to  characterize  a  potentially  novel  phenotype.  Our
ultimate aim was to identify the gene responsible for this
apparently-autosomal-dominant disorder.
From the genealogy of the index cases [11] we identified
the  living  members  of  five  lineal  generations,  as  well  as
surviving  more-distant  relatives.  We  invited  these  family
members for a comprehensive ophthalmic examination [12],
including:
TABLE 1. MICROSATELLITE PRIMERS AND CONDITIONS.
Marker Primer names and sequences (5’-3’) Size (bp) Annealing
temperature
Amplification conditions
D11S4187 F TCTTGAACCCGGGAAG 273-289 55 °C Invitrogen Taq & buffer
  R CTGGTGCTGTGCTTGG      
D11S896 F ATCTCCCCTAGCTGTTTTGGA 169-183 60 °C Invitrogen Taq & buffer
  R AGTTCATATCCACCTCACACA      
D11S1367 F GCTGACATTTATTCACATGGC 224-244 60 °C Invitrogen Taq & buffer
  R ACAGTGTTATCTCCCTGGCA      
D11S2006 F CTTGTGGGCTGTAGTTTGCT ~325 55 °C Invitrogen Taq & buffer
  R AAAGAGTAAACTCAATGAAAGATGC      
D11S4095 F TCCCTGGCTATCTTGAATC 173-205 55 °C Invitrogen Taq & buffer
  R CTTGACTGGGTCCACG      
D11S937 F CTAATAAACAAATCCCTCTACCTCC 230-264 60 °C Invitrogen Taq & buffer
  R TAGTCAGTCAGGGACCCAAGT      
D11S929 F AGGCCCTTCCAAGATCAG 218-240 60 °C Invitrogen Taq & buffer
  R CCCAGTTGCCGAACTACC      
D11S4115 F TGGCATGTAAATNTAAGAGACTCAC 185-199 50 °C Invitrogen Taq & buffer
  R CTGCTACCTCAGAAGTATCTCAA      
D11S4154 F ATCCCTTGGCTTTCTCAGAGCAC 146-158 65 °C Invitrogen Taq & buffer
  R GGTGCCCCTAACCTCCATGT      
D11S4203 F GAATAGCCACTGACTTCAGG 218-278 60 °C Invitrogen Taq & buffer
  R CAGGATGCTGGAATAGAGAA      
D11S4083 F TTTAACCCAAGGGCAGGAC 178-206 55 °C Invitrogen Taq & buffer
  R CATGTGTACCCAAGGGCAG      
D11S4102 F CACCACTGGGTACTGCCATC 142-174 60 °C Invitrogen Taq & buffer
  R GCTAAATCCTGGAAAGCCCTG      
TABLE 2. TSPAN12 PRIMERS AND PCR CONDITIONS.
Exon Primer names and sequences (5’-3’) Size (bp) Annealing temperature Amplification conditions
2 TSPAN12-ex2-F ATGTCCCGTGTTCTCTCTCC 382 60 °C Invitrogen Taq & buffer
  TSPAN12-ex2-R CCAGGGGTGGATTTCTTTGT      
3 TSPAN12-ex3-F TGGTAATTGGGAAAGATATTATGTAAC 291 60 °C Invitrogen Taq & buffer
  TSPAN12-ex3-R CCAAAAGATCAAGGAAGAGCA      
4 TSPAN12-ex4-F TGAGGCATCATGATTGAAAGAA 346 60 °C Invitrogen Taq & buffer
  TSPAN12-ex4-R GCTATCACTGCTCCCTAATCTTGT      
5 TSPAN12-ex5-F GGTCCCCTTTCTTGGAGAAC 947 60 °C Invitrogen Taq & buffer
  TSPAN12-ex5-R TGGAAATGTGCTTTAGACACAGA      
6 TSPAN12-ex6-F GTACAAAATACCTCTTCATTTATCACA 529 60 °C Hot shot master mix
  TSPAN12-ex6-R GAAGAAAAGCAGGCCATGAA      
7 TSPAN12-ex7-F TGATGACAGATATAGCTCTGGGT 376 60 °C Hot shot master mix
  TSPAN12-ex7-R TTTTAAGGCCTTTTACATTTAGACA      
8 TSPAN12-ex8-F GCTTTCCCTGAGAACCACTG 605 60 °C Hot shot master mix
  TSPAN12-ex8-R CCATCCTCATTTTAAAGCATAGA      
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2119•a LogMAR visual acuity test,
•the  Goldmann  applanation  intraocular  pressure
(IOP) measurement,
•refraction using a HARK-598 autorefractor (Carl
Zeiss Meditec, Miami, FL),
•axial  length  measurement  using  an  Ocuscan®
(Alcon, Inc., Ft Worth, TX),
•corneal  pachymetry  using  an  IOPac  (Heidelberg
Instruments, Heidelberg, Germany),
•lens photographs,
•stereoscopic optic disc photography using a Nidek
3Dx camera (Nidek, Gamagori, Japan), and
•examination of the peripheral retina.
All  participants  provided  venous  blood  or  saliva
specimens for DNA extraction and genetic analysis.
Genotyping was performed using fluorescently-tagged
microsatellite markers as described previously [13]. Briefly,
standard PCR reactions were carried out in a 25 μl volume
containing 50 ng of genomic DNA using Invitrogen Taq DNA
polymerase and buffers (Invitrogen). Microsatellite markers
(including  primer  details;  Table  1)  surrounding  EVR1
(D11S4187, D11S896, and D11S1367), EVR4 (D11S2006,
D11S4095, and D11S937) and EVR3 (D11S929, D11S4115,
D11S4154,  D11S4203,  D11S4083,  and  D11S4102)  were
selected from the genome browser. Following amplification,
PCR  products  were  resolved  using  an  ABI  3730  DNA
sequencer and analyzed using GeneMapper® software from
the same manufacturer (Applied Biosystems, Carlsbad, CA).
The coding sequence and surrounding exons of myocilin,
trabecular  meshwork  inducible  glucocorticoid  response
(MYOC)  and  tetraspanin  12  (TSPAN12;  primers  and
conditions are listed in Table 2) were screened using standard
direct  sequencing  protocols  as  described  previously  (see
above) [14,15].
For the genotyping platform, we used Linkage Panel IVb
of  6008  genome-wide  single-nucleotide  polymorphisms
(SNPs; Illumina, San Diego, CA), and ran the analysis at the
Center  for  Inherited  Disease  Research  (CIDR)  of  Johns
Hopkins  University  (Baltimore,  MD).  The  results  for  the
pedigree were analyzed with Fastlink using a 2-point analysis
(under a dominant model); multipoint results (both parametric
and non-parametric) were analyzed using MERLIN. Merlin
(Multipoint  Engine  for  Rapid  Likelihood  Inference)  is  a
software  package  that  uses  sparse  inheritance  trees  for
pedigree analysis [16].
RESULTS
Genealogical information was available for nine generations
of the participants’ family; the individuals examined for this
study came from the five most recent generations.
•Figure 1 shows the relevant portions of the full
pedigree. A consanguineous loop enriched the pedigree
with similar genes (RELPAIR [17] analysis suggested a
grandparent-grandchild  relationship  when  they  were
actually great-grandparent and great-grandchild). 
•Table  3  displays  the  participants’  ophthalmic
phenotypes  with  autorefraction  sphere  and  cylinder,
Keratometry readings, and axial length.
•Figure 2 and Figure 3A-N show photos of the optic
disc, retina, and lens.  
•Figure 4A-E show visual field defects. 
Excluding the married-in spouses, we examined eight
female and six male family members aged 3–86 years who
apparently were affected.
•Visual acuity ranged from 6/5 to perception of light.
•Spherical-equivalent  refractive  error  in  Diopters
(D) ranged from +0.25 D to −11.0 D, with five individuals
having myopia in at least one eye of <-3D.
•Astigmatism varied from 0 to −7.25 D with the rule
or −5 D against the rule.
•Axial length varied from 23.75 mm to 26.77 mm.
•Keratometry  readings  in  eyes  that  had  not  been
operated on ranged from 40.0 D to 48.62 D, with the
largest corneal astigmatism measuring only 3.12 D.
•Maximum recorded IOP ranged from 13 mmHg to
36 mmHg.
•Central corneal thickness ranged from 510 μm to
590 μm.
•One male (VIII:6) was found to have a distance
exotropia of 25 D.
•Twelve individuals (6 male and 6 female) had CC,
thought to be pediatric in onset. (V:2, V:4,VI:7, VI:12,
VII:3, VII:5, VII:3, VII:7, VIII:3, VIII:5, VIII:6, VIII:7,
IX:1). The youngest age of documented cataract was 3
years of age (IX:1).
•One member (VIII:7) had photographic evidence of
cataract  progression  (Figure  3J,K).  In  addition,  iris
atrophy was noted at the 3 and 9 o’clock positions. This
atrophy possibly became more notable with age (Figure
3K).
•One  female  individual  (VIII:8)  had  severe
spontaneous retinal detachment consistent with FEVR,
while five individuals (3 male and 2 female) had dragged
retinal vessels (V:4,VI:7, VII:5, VII:7, VIII:7).
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2120•Seven individuals (5 female and 2 male) had been
diagnosed with POAG (V:2, V:4, VI:7, VI:12, VI:13,
VII:5, VII:7).
Cataract  extraction  was  performed  on  VII:7  after  the
cortical wedge progressed to complete lenticular opacification
in the left eye and vision declined from 6/18 to 6/60. Post-
operatively,  this  member’s  best-corrected  visual  acuity
improved to 6/6. Refraction in the left eye changed from
−6.25/-1.5x145  to  +0.00/-0.50  X  98  following  cataract
surgery. The brother of this individual (VII:5) had similar
surgery for cataract and astigmatism, but his visual acuity did
not improve from 6/60.
Systemic associations: None of the family members had
dysmorphia or an unusual stature consistent with the facial or
body habitus features of Stickler syndrome. One member,
who had not worn ear protection in his industrial employment,
had noise-related hearing loss (VII:7) and one (V:4) had age-
related hearing loss. Only one member (V:4) was found to
have a single café-au-lait spot.
One participant (VII:7) had previously been diagnosed
with pulmonary alveolar proteinosis (PAP) and treated with
repeated pulmonary lavage. PAP is a rare disorder related to
the receptor pathway of the granulocyte macrophage–colony
stimulating factor (GM-CSF); it was diagnosed after recurrent
bouts of pneumonia in adult life. No other family member has
Figure 1. Reduced pedigree showing affected individuals. Square=male, circle=female, Top Right filled=myopia, Bottom Right
filled=retinal detachment or dragged disc, Bottom Left filled=cataract, Top Left=primary open-angle glaucoma (POAG), n=examined
and normal.
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yexperienced similar medical problems; no individual reported
any renal problems.
MYOC screening of the index case revealed no mutation
[14]. Haplotype analysis of a central portion of the pedigree
excluded the EVR1 frizzled family receptor 4 (FZD4) and
EVR4  low  density  lipoprotein  receptor-related  protein  5
(LRP5)  FEVR  genes  (Figure  4).  Unfortunately,  the  EVR3
locus could be only partially excluded due to uninformative
markers. Given that this gene had not been identified, we
cannot exclude this locus fully. Direct screening of VIII:8
excluded the recently-identified FEVR gene TSPAN12.
The  family  was  included  in  the  International  High
Myopia  Consortium  linkage  analysis  [16];  however,  the
family  was  dropped  from  the  multipoint  analyses  for
Figure 2. Lens, optic disc, and retina photos of individuals. In the figure, A indicates individual V:2; B indicates individual V:4;
C indicates individual VI:7; D indicates individual VII:3; E indicates individual VII:5; F indicates individual VII:7; G indicates individual
VIII:3; H indicates individual VIII:5; I indicates individual VIII:6; J indicates individual VIII:7; K indicates individual VIII:7 followup
lens photo five years after first photos; L indicates individual VIII:8; M indicates individual VIII:9; and N indicates individual IX:1.
Figure 3. 24–2 Humphrey Visual Fields of Individuals. A indicates individual V:2; B indicates individual V:4; C indicates individual
VI:7; D indicates individual VII:5; and E indicates individual VII:7.
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2123chromosomes 3, 4, 6, 7, 8, 11, and 12 due to the pedigree’s
complexity. Table 4 displays the two-point linkage results for
this family showing the highest scoring logarithm of odds
(LOD) scores above 1.5. There were multiple chromosomal
SNPs  of  interest,  but  no  statistically  significant  focal
localization.
DISCUSSION
This  Australian  pedigree  has  a  unique  constellation  of
ophthalmic features that do not appear to have been described
previously. Although we were unable to identify a similar
family  reported  in  the  literature,  the  subtle  and  relatively
common clinical features could be overlooked.
Many investigators have reported the association of high
myopia  with  ocular  morbidities  of  early-onset  cataract,
glaucoma and retinal detachment [5]. Pedigrees with myopia
are common, but pedigrees with so many members affected
with these early ocular issues along with myopic development
are extremely rare; we were not able to identify any in the
published literature.
Although we cannot discount that the associated ocular
features may be secondary in origin, this family raises the
possibility that the same gene may be responsible for all forms
of the pathology observed in the pedigree.
Retinal detachment is an uncommon disorder in young
people  and  is  most  commonly  identified  in  patients  with
FEVR.  X-linked  FEVR  and  Norrie  disease  arose  from
mutations in Norrin (excluded by male-to-male transmission,
in this pedigree). Dominant FEVR is due to mutations in
FZD4 and LRP5, and has been linked to the EVR3 locus
[18]. We excluded these loci through linkage analysis. The
recently-described gene TSPAN12 (EVR5) was excluded by
sequence analysis. Nonetheless, despite a well characterized
FEVR mutation, there still can be considerable variation in
the expressivity of the phenotype and incomplete penetrance
[15,18,19] (Personal communication; T.L. Edwards, Centre
for Eye Research Australia, Melbourne, Australia [article in
press]).
Since  the  cataract  is  the  most  “easily  characterized”
phenotype in this family’s pedigree, we compared it with other
cataract phenotypes described in the literature. Although CC
has been linked to or associated with many cataract loci and
many chromosomal deletions, the causative mutation has not
Figure 4. Haplotype analysis of FEVR genes. Only a subset of the pedigree is displayed; shaded individuals are those whose
phenotype suggests FEVR. EVR2 (Norrin) is excluded by the pedigree structure showing male to male transmission. For each locus
examined, the affected individuals do not share the same haplotype, indicating that the causative gene does not reside in this region of
the chromosomal. A: EVR1 (FZD4); B: EVR3 11p13-p12; C: EVR4 (LRP5).
Molecular Vision 2011; 17:2118-2128 <http://www.molvis.org/molvis/v17/a230> © 2011 Molecular Vision
2124TABLE 4. SUMMARY OF THE JOHNS HOPKINS CENTER FOR INHERITED DISEASE RESEARCH (CIDR) RESULTS FOR THE FAMILY.
Chromosome Marker Position (cM) 2PT-parametric
(Fastlink)
MPT-non-
parametric
MPT-parametric
1 rs1981193 121.82 1.863 NS NS
1 rs1806753 160.34 1.079 NS NS
2 rs2053372 47.98 1.592 NS NS
2 rs2008535 54.9 1.128 NS NS
2 rs764464 65.31 1.328 NS NS
2 rs1022298 117.27 1.162 NS NS
2 rs264963 117.39 1.162 NS NS
3 rs2076993 46.5 1.166 NS NS
3 rs1348979 49.44 1.166 NS NS
3 rs1127732 59.51 1.097 NS NS
3 rs713144 60.4 1.477 NS NS
3 rs1382554 60.41 1.097 NS NS
3 rs1405793 64.61 1.159 NS NS
3 rs1495704 65.68 1.159 NS NS
3 rs1995137 66.29 1.159 NS NS
3 rs1351631 67.73 1.522 NS NS
3 rs737516 67.73 1.522 NS NS
3 rs1013758 67.81 1.522 NS NS
3 rs844438 78.91 1.123 NS NS
3 rs1447971 82.11 1.842 NS NS
3 rs935734 92.98 1.586 NS NS
3 rs1019374 95 1.069 NS NS
3 rs1388276 99.96 1.116 NS NS
4 rs751266 67.19 1.054 NS NS
4 rs896656 93.96 1.326 NS NS
8 rs2203837 23.58 1.615 NS NS
8 rs334206 32.33 1.241 NS NS
8 rs241202 48.58 1.849 NS NS
8 rs4107736 50.87 1.248 NS NS
8 rs1481747 53.13 1.103 NS NS
8 rs1955185 61.16 1.05 NS NS
8 rs716583 65.56 1.116 NS NS
8 rs344278 74.88 1.582 NS NS
8 rs1460239 112.26 1.618 NS NS
8 rs1433396 122.14 1.119 NS NS
8 rs766811 138.68 1.16 NS NS
9 rs1532310 0.124137 1.522 NS NS
9 rs1532309 0.124434 1.522 NS NS
9 rs1143025 30.9 1.176 NS NS
9 rs1029015 35.12 1.767 NS NS
9 rs716933 60.37 1.089 NS NS
9 rs987187 60.4 1.128 NS NS
9 rs1333342 69.96 1.477 NS NS
10 rs1346300 75.86 1.522 NS NS
11 rs676943 125.79 1.015 NS NS
12 rs871880 58.31 1.123 NS NS
12 rs7134835 161.7 1.2 NS NS
12 rs1278602 171.56 1.089 NS NS
12 rs1278601 171.57 1.089 NS NS
12 rs937538 171.78 1.094 NS NS
Molecular Vision 2011; 17:2118-2128 <http://www.molvis.org/molvis/v17/a230> © 2011 Molecular Vision
2125been identified for the majority of CC and pediatric cataract
cases [6].
The peripheral cortical lamella wedge seen in this family
is similar to that observed in Stickler syndrome [7] and also
with neurofibromatosis Type 2 (NF2) [20]. Interestingly, one
case  describes  NF2  associated  with  posterior  subcapsular
cataract and dragged disc [21]. In a series of 15 other NF2
patients,  12  patients  had  an  epiretinal  membrane  in  the
macular  or  paramacular  area  and  11  patients  had  central
posterior  cortical,  subcapsular,  or  peripheral  cortical  lens
opacities [22]. NF2 arises from mutations in the Merlin gene
on chromosome 22q12.2 [23].
The one case of PAP [24] prompted an investigation of
possible genes involved in the GM-CSF pathway using the
Online Mendelian Inheritance in Man® (OMIM) database at
Johns Hopkins University. Of three loci associated with PAP,
one  gene  located  at  chromosome  22q12.2-q13.1,
Granulocyte-macrophage Colony-stimulating factor receptor,
beta (CSF2RB) is adjacent to Merlin. Notably, on reviewing
myopia loci, the myopia linkage found by Stambolian and
colleagues  [25]  for  marker  D22S685  lies  in  chromosome
region 22q12. This region has also been replicated in the
Beaver Dam Eye study [26].
The refractive error recorded in this pedigree is atypical;
most  hereditary  myopia  is  symmetric  and  usually  is  not
associated with high astigmatism. To date there has been little
investigation of the genetics of astigmatism, though genetic
factors are likely to play a role [27]. It would appear that the
myopia in this family originates in increased axial length
rather than in the more usual primary lenticular fault. The
degree  of  astigmatism  in  severely  affected  members,
however,  appeared  to  be  both  lenticular  and  corneal,
suggesting a common mechanism of growth or compensation.
The causative interaction of the cataract and the increased
TABLE 4. CONTINUED.
Chromosome Marker Position (cM) 2PT-parametric
(Fastlink)
MPT-non-
parametric
MPT-parametric
13 rs2985981 49.25 1.004 NS NS
13 rs2031836 115.73 1.003 NS NS
15 rs1435735 46.31 1.199 NS NS
15 rs890153 46.31 1.554 NS NS
15 rs725463 60.22 1.043 NS NS
15 rs1445020 71.05 1.049 NS NS
16 rs1019141 19.98 1.49 NS NS
16 rs889593 122.83 0.018 0.701998 1.0217
16 rs299956 123.93 0.734 0.943619 1.5971
16 rs2076962 125.29 −0.036 1.127055 1.8771
16 rs3794668 126.97 −0.011 1.126755 1.8763
16 rs1056707 128.94 0.057 1.12803 1.8782
16 rs750740 129.03 0.399 1.128125 1.8783
16 rs463701 130.14 −0.067 1.129806 1.8804
16 rs452176 130.21 0.01 1.129825 1.8804
16 rs1006547 130.48 0.018 1.129924 1.8805
16 rs1800330 130.5 0.891 NS NS
16 rs870856 130.83 1.781 1.126244 1.8762
16 rs8577 130.86 0.549 1.125715 1.8755
17 rs721429 95.95 1.199 NS NS
18 rs1972602 45.77 1.123 NS NS
18 rs1548755 51.57 1.252 NS NS
18 rs1131709 56.82 1.339 NS NS
18 rs650680 58.25 1.767 NS NS
18 rs931078 84.57 1.11 NS NS
20 rs1535382 14.16 1.046 NS NS
21 rs1041756 33.98 1.07 NS NS
21 rs2839576 62.26 1.324 NS NS
       2-point analyses with Fastlink under a dominant model; multipoint results, both parametric and non-parametric, using the
       multipoint engine for rapid likelihood inference (MERLIN ). Results in italics highlight suggestive loci, while the results in bold
       were found to be suggestive under all models tested. Abbreviations: Chr, chromosome; cM, centimorgan; 2PT, two point; MPT,
       multi-point; NS, not significant.
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deprivation [28].
We hope that characterization of this unusual phenotypic
constellation  will  identify  other  families  with  similar
characteristics. Further characterization of the genes involved
in  this  family  using  methods  such  as  next-generation
sequencing should help shed light on the genetics of the four
clinical entities —POAG, CC, FEVR, and myopia— as well
as their interactions. In time, this further work also may help
clarify  the  molecular  pathways  of  developing  myopia
involving retinal signaling, lens growth and axial length.
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